| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/03/2009 | CA2718676A1 Divalent hydrazide compound conjugates for inhibiting cystic fibrosis transmembrane conductance regulator |
| 12/03/2009 | CA2668245A1 Improved laxative composition and method |
| 12/02/2009 | EP2128095A1 Spherical ferrite nanoparticle and method for production thereof |
| 12/02/2009 | EP2127687A1 Composition for treatment of cartilage disease |
| 12/02/2009 | EP2127681A1 Therapeutic agent for periodontal disease and alveolar bone loss due to surgery |
| 12/02/2009 | EP2127680A1 Use of carbon nanotube for drug delivery. |
| 12/02/2009 | EP2127679A1 SlpA as a tool for recombinant protein and enzyme technology |
| 12/02/2009 | EP2127678A1 SlpA as a tool for recombinant protein and enzyme technology |
| 12/02/2009 | EP2127677A1 Aminoalkylmethacrylate copolymer e for maintaining solubility of poorly water-soluble drug |
| 12/02/2009 | EP2127670A1 Liposome for induction of cell-mediated immunity |
| 12/02/2009 | EP2127658A1 Therapeutic agent for meniere s disease |
| 12/02/2009 | EP2127651A1 Stabilized medicinal composition containing donepezil, method of producing the same and method for stabilization |
| 12/02/2009 | EP2127649A1 Composition for promoting bioabsorption of flavonoid, food/beverage for promoting bioabsorption of flavonoid using the composition, and method for production of the food/beverage |
| 12/02/2009 | EP2127646A1 Agent for relief or prevention of xerostomia |
| 12/02/2009 | EP2127642A2 Microemulsions as solid dosage forms for oral administration |
| 12/02/2009 | EP2127640A1 Azide modified proteins |
| 12/02/2009 | EP2127638A1 Method and composition for treating ocular hypertension and glaucoma |
| 12/02/2009 | EP2127520A1 Gel-like sterilizing/disinfecting composition |
| 12/02/2009 | EP2126158A1 Manufacturing method of medical sterilized isotonic solution having low-concentratedly controlled free chlorine including hypochlorous acid therein |
| 12/02/2009 | EP2126055A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3. |
| 12/02/2009 | EP2125855A2 Methods and compositions for the treatment of cancer or other diseases |
| 12/02/2009 | EP2125031A2 Lipids and lipid assemblies comprising transfection enhancer elements |
| 12/02/2009 | EP2125030A2 Chitosan-based colloidal particles for rna delivery |
| 12/02/2009 | EP2125029A2 Construction and use of transfection enhancer elements |
| 12/02/2009 | EP2125028A1 Polymer-coated nanoparticles |
| 12/02/2009 | EP2125027A2 De novo synthesis of conjugates |
| 12/02/2009 | EP2125026A2 Bridged polycyclic compound based compositions for the inhibition and amelioration of disease |
| 12/02/2009 | EP2125025A2 Multi-functional drug carriers |
| 12/02/2009 | EP2125024A2 Targeted intracellular delivery of antiviral agents |
| 12/02/2009 | EP2125023A2 Soluble forms of inclusion complexes of histone deacetylase inhibitors and cyclodextrins, their preparation processes and uses in the pharmaceutical field |
| 12/02/2009 | EP2125022A2 Golden mean harmonized water and aqueous solutions |
| 12/02/2009 | EP2124961A2 Novel composition based on cholest-4-ene-3-one oxime |
| 12/02/2009 | EP2124931A1 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
| 12/02/2009 | EP2124929A1 A two-component taxane containing pharmaceutical composition |
| 12/02/2009 | EP2124906A1 Polypeptide films and methods |
| 12/02/2009 | EP2124897A1 Stable anti-nausea oral spray formulations and methods |
| 12/02/2009 | EP2124894A2 Aqueous formulations |
| 12/02/2009 | EP2124893A1 Pharmaceutical compositions comprising a calcilytic agent |
| 12/02/2009 | EP2124892A2 Use of a highly emulsified silicone oil (hes) for the production of a medicament |
| 12/02/2009 | EP2124890A2 Use of sucrose to suppress mannitol-induced protein aggregation |
| 12/02/2009 | EP2124889A2 Protein formulations containing sorbitol |
| 12/02/2009 | EP2124886A2 Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer |
| 12/02/2009 | EP2124883A2 Pharmaceutical formulations and methods for making the same |
| 12/02/2009 | EP2124881A1 Ciclesonide containing sterile aqueous suspension |
| 12/02/2009 | EP1684801B1 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 12/02/2009 | EP1666043B1 Product containing prostaglandin |
| 12/02/2009 | EP1534670B1 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs |
| 12/02/2009 | EP1534347B1 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds |
| 12/02/2009 | EP1487416B1 Drug microparticles |
| 12/02/2009 | EP1463440B1 Prevention of flap necrosis in plastic surgery |
| 12/02/2009 | EP1435909B1 Stable composition comprising particles in a frozen aqueous matrix |
| 12/02/2009 | EP1326500B1 Encased food product with contrasting components |
| 12/02/2009 | EP1313820B1 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives |
| 12/02/2009 | EP1272179B1 Hydrophilic molecular disperse solutions of carvedilol |
| 12/02/2009 | EP1260220B1 Bubbling tablet, bubbling bath additive tablet, bubbling washing detergent tablet, bubbling tablet for oral administration, and processes for producing these |
| 12/02/2009 | CN101595213A Cancerous disease modifying antibodies |
| 12/02/2009 | CN101594891A Film-forming gel composition for wound or skin care |
| 12/02/2009 | CN101594865A Pharmaceutical composition containing low-substituted hydroxypropylcellulose |
| 12/02/2009 | CN101594863A Film-coated preparation having improved stability |
| 12/02/2009 | CN101594780A Agents for controlling parasites on animals |
| 12/02/2009 | CN101591818A Shikonin PCL/PTMC composite nanometer fiber and preparation and application thereof |
| 12/02/2009 | CN101591649A Methoxypolyethylene glycol-modified arginine deiminase, preparation thereof and use thereof |
| 12/02/2009 | CN101591444A Method for preparing laminar large composite vesicles from acrylamide and acrylic acid copolymer |
| 12/02/2009 | CN101591432A Polyethyleneglycol-aliphatic poly (ester-carbonic ester) with allyl lateral group, preparation method thereof and application thereof |
| 12/02/2009 | CN101591397A Recombinant expression and application of long-acting thymosin alpha1 |
| 12/02/2009 | CN101591235A Method for producing low lead granular magnesium citrate |
| 12/02/2009 | CN101591234A Method for producing magnesium citrate |
| 12/02/2009 | CN101590291A Gel composition for medical material or hygiene material, molded article thereof and adhesive material or adhesive preparation using same |
| 12/02/2009 | CN101590242A Method for preparing chitosan or sodium alginate-modified carbon nanotube-targeted slow release carrier |
| 12/02/2009 | CN101590241A Cisplatin nano-micelle prodrug and preparation method thereof |
| 12/02/2009 | CN101590224A High-efficiency 14-valent pneumococcal conjugate vaccine |
| 12/02/2009 | CN101590221A Oral insulin medicament and preparation method thereof |
| 12/02/2009 | CN101590220A Method for preparing interferon liposome injection |
| 12/02/2009 | CN101590214A Ear patch for reducing weight |
| 12/02/2009 | CN101590162A Yidanshu slow-release tablet for treating pancreatitis or cholecystitis and preparation method thereof |
| 12/02/2009 | CN101590155A Patch for treating miocardial infarction |
| 12/02/2009 | CN101590152A Preparation method of Bawei Chenxiang capsule |
| 12/02/2009 | CN101590143A External ointment formulation for treating blepharitis marginalis and preparation process thereof |
| 12/02/2009 | CN101590130A Patch for treating constipation |
| 12/02/2009 | CN101590108A Method for changing viscosity of Magnolia extractive |
| 12/02/2009 | CN101590099A Addie micro-emulsion and preparation method thereof |
| 12/02/2009 | CN101590085A Body odor-removing powder |
| 12/02/2009 | CN101590083A Yinxingdamo oral preparation equivalent to similar intravenous preparation |
| 12/02/2009 | CN101590077A Compound erythromycin zinc acetate ointment for local use |
| 12/02/2009 | CN101590061A Medicinal composition of cefotetan disodium |
| 12/02/2009 | CN101590055A Water soluble decoquinate and method for preparing same |
| 12/02/2009 | CN101590054A Lovastatin and niacin sustained-release tablet and preparation method thereof |
| 12/02/2009 | CN101590050A Medicine for treating allergic rhinitis and preparation method thereof |
| 12/02/2009 | CN101590042A Stable oral medicinal composition |
| 12/02/2009 | CN101590033A Medicinal composition fat emulsion injection containing eucalyptol, limonene and alpha-pinene and preparation method |
| 12/02/2009 | CN101590029A Propofol composition |
| 12/02/2009 | CN101590028A Tulobuterol-containing aquogel patch and preparation method thereof |
| 12/02/2009 | CN101590027A Chewing soft capsule and preparation method thereof |
| 12/02/2009 | CN101590025A Simvastatin slow-release tablet and preparation method thereof |
| 12/02/2009 | CN101590023A Clopidogrel hydrogen sulfate tablet and preparation method thereof |
| 12/02/2009 | CN101590022A Theophylline sodium glycinate slow-release tablet and preparation method thereof |
| 12/02/2009 | CN101590021A Cefuroxime axetil odor-masking pellet and preparation method |
| 12/02/2009 | CN101590020A Para-aminosalicylate colon positioning drug delivery system |
| 12/02/2009 | CN101590017A Method for preparing taxol magnetic nano liposome |
| 12/02/2009 | CN101590016A Ivermectin emulsion for injection and preparation method thereof |